Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

The FDA has expanded the label of Ozempic, approving the Novo Nordisk product for reducing the risk of worsening kidney disease and kidney failure as well as reducing the risk of death.

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

(Menopause) The Ohio State University Wexner Medical Center Comprehensive Transplant Center set a record-breaking kidney "donation chain," with 20 surgeries over a 2-day period. (Columbus Dispatch ...

AstraZeneca's fast-growing SGLT2 inhibitor Forxiga could soon get a further boost from approval in the EU as a treatment for chronic kidney disease (CKD) in adults with and without type-2 diabetes.

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the label of Ozempic. Novo Nordisk estimates that around 40% of people with ...